Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

558
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
558
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

807
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
807
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

594
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
594
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

3.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

870
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
870
Decreased pulse rate01:14

Decreased pulse rate

1.1K
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Less is more in cardiology and angiology].

Der Internist·2021
Same author

Increased risk of acute stroke among patients with severe COVID-19: a multicenter study and meta-analysis.

European journal of neurology·2020
Same author

[Implementation of anesthesia quality indicators in Germany : A prospective, national, multicenter quality improvement study].

Der Anaesthesist·2020
Same author

Anticoagulation treatment of cancer patients with deep or superficial leg vein thrombosis - a retrospective observational study of German statutory health insurance claims data (the CERTIFICAT initiative).

VASA. Zeitschrift fur Gefasskrankheiten·2020
Same author

Implementation of anesthesia quality indicators in Germany : A prospective, national, multicenter quality improvement study.

Der Anaesthesist·2020
Same author

Imaging of coronary arteries using ionic versus non-ionic radiographic contrast media: Intraindividual comparison study.

Clinical hemorheology and microcirculation·2019
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

22.2K

[Cardiogenic syncope].

U Gerk1, G Simonis, J Machetanz

  • 1II. Medizinische Klinik, Städtisches Klinikum Dresden-Friedrichstadt, Friedrichstr.41, 01067, Dresden, Deutschland, gerk-ul@khdf.de.

Der Internist
|December 24, 2014
PubMed
Summary
This summary is machine-generated.

Diagnosing cardiogenic syncope requires a thorough medical history, physical exam, ECG, and echocardiogram. Rhythmogenic syncope and drug-induced causes present diagnostic challenges, necessitating specialized tools.

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.1K
Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.6K

Related Experiment Videos

Last Updated: Apr 19, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

22.2K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.1K
Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.6K

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Diagnostic Imaging

Context:

  • Cardiogenic syncope is a critical medical event requiring prompt diagnosis.
  • Identifying the underlying cause is essential for effective patient management.
  • Various factors, including cardiac arrhythmias and medications, can precipitate syncope.

Purpose:

  • To outline the diagnostic approach for cardiogenic syncope.
  • To highlight the challenges in diagnosing rhythmogenic syncope.
  • To emphasize the importance of considering drug-induced syncope.

Summary:

  • A comprehensive medical history and physical examination are foundational for syncope evaluation.
  • Electrocardiogram (ECG) and echocardiography are key diagnostic tools for identifying cardiac causes.
  • Specialized electrophysiological studies and Holter monitoring are often required for rhythmogenic syncope.
  • Medication review is crucial, as certain drugs can induce syncope through various mechanisms.

Impact:

  • Facilitates timely and accurate diagnosis of cardiogenic syncope.
  • Improves patient outcomes by enabling targeted treatment strategies.
  • Enhances clinical awareness of challenging syncope etiologies, including drug-induced and rhythmogenic causes.